Signaling Pathways - RET - NTPDases - EZH2 - adrenoceptor
清除全部
- B7113 PSB 06126Target: NTPDasesSummary: NTPDase 3抑制剂
- B6552 CGP 20712 dihydrochlorideTarget: adrenoceptorSummary: β1拮抗剂
- B4678 CPI-1691 CitationTarget: EZH2|EZH1Summary: EZH2抑制剂
- B1583 UNC19992 CitationTarget: EZH2|EZH1Summary: EZH2抑制剂
- A8474 Mirabegron (YM178)中文名: 米拉贝隆Target: adrenoceptorSummary: 选择性β3肾上腺素受体激动剂
- A2174 Lenvatinib (E7080)中文名: 乐伐替尼,仑伐替尼Target: VEGFR|PDGFR|RETSummary: VEGFR抑制剂
- A8236 Regorafenib4 Citation中文名: 瑞戈非尼Target: Raf|VEGFR|PDGFR|c-Kit|RETSummary: VEGFR/PDGFR/FGFR/mutant Kit/RET/Raf-1抑制剂
- A3449 GSK3431 CitationTarget: EZH2Summary: EZH2抑制剂
- A3446 GSK1265 CitationTarget: EZH2Summary: EZH2抑制剂
- A3194 AST 4871 CitationTarget: RETSummary: RET激酶抑制剂